Search Results

As we approach breast cancer awareness month tomorrow Maryland Oncology Hematology is proud to be partnering with Lifetime and The Breast Cancer Research Foundation for their 27th year of “Stop Breast Cancer for Life.” Our lives have changed, but what hasn’t is our fight against breast cancer. Lifetime has proudly supported breast cancer research for…

Maryland Oncology Hematology is excited to announce our first Tv campaign and share those spots with all of you.  

As of Friday August 13th, the CDC is now recommending that people with moderate to severe compromised immune systems should receive an additional dose (booster) of the COVID-19 vaccine after the initial two-dose vaccine series. At MOH, many of our patients have moderately to severely compromised immune systems and do not always build the same…

Cancer is a collective term referring to many different diseases. Simply put, cancer is uncontrolled cell growth, which can lead to tumor formation. A non-invasive tumor (in situ cancer) remains within the tissue where it originated. A malignant tumor (invasive cancer) has potential to spread to neighboring tissues and can form new tumors (metastases) elsewhere…

A Partnership Between Physicians and Their Community Maryland Oncology Hematology believes in providing patients with advanced, comprehensive cancer therapies in a community setting that allows patients to receive care near their support systems. Our highly trained and experienced physicians work closely with a talented clinical team that is sensitive to the needs of cancer patients…

The Coronavirus: Did we need a vaccine? Every aspect of the Coronavirus disease 19 (COVID-19) pandemic has occurred at record speeds, from disease transmission to vaccine development. COVID-19, caused by a novel coronavirus known as SARS-CoV-2, targets the respiratory system. Most people experience flu-like symptoms; however, in the elderly and those with comorbidities, mild respiratory…